Key result
Higher total adiponectin is linked to ~40% lower risk of insulin resistance.
Why the study?
Reduction of adiponectin is associated with obesity-related disorders including insulin resistance, but its predictive value for insulin resistance in metabolically healthy and diabetic adults was unclear.
Do higher levels of total and high-molecular-weight adiponectin predict a lower risk of insulin resistance in middle-aged European adults?
Observational (n=569)
Do higher levels of total and high-molecular-weight adiponectin predict a lower risk of insulin resistance in middle-aged European adults?
Total and high-molecular-weight adiponectin levels below specific cut-offs (4.22 mg/L and 2.75 mg/L, respectively) may predict a potential risk for the development of insulin resistance in middle-aged European adults.
Answers are grounded in this paper and cite their sources.
Adiponectin levels may aid IR risk stratification in middle-aged Europeans; cross-sectional data leaves predictive value and causality open.
INTRODUCTION: Adiponectin is a peptide secreted by adipocytes; its reduction is associated with obesity-related disorders, including insulin resistance (IR). The study analysed levels of total adiponectin and its high-molecular-weight (HMW) oligomer in a group of metabolically healthy adults and in patients with type 2 diabetes mellitus (T2DM) to evaluate these levels as potential predictors of the presence of IR. MATERIALS AND METHODS: The study comprised 269 metabolically healthy adults and 300 patients with T2DM. Anthropometric and bio-chemical indices were measured, including total and HMW adiponectin levels; the Homeostatic Model Assessment of IR (HOMA-IR) index was calculated, and logistic regression analysis was used to predict the presence of IR. RESULTS: In healthy individuals, both total and HMW adiponectin levels were significantly higher than in diabetic patients. Total and HMW adiponectin levels were moderately correlated with the HOMA-IR index. Logistic regression analysis showed that increased levels of both total adiponectin (odds ratio [OR] 0.598, 95% confidence interval [CI] 0.483-0.723) and the HMW form (OR 0.360, 95% CI 0.242-0.511) are protective factors for the development of IR. The cut-off levels were 4.22 mg/L for total adiponectin and 2.75 mg/L for HMW adiponectin. The results are valid for middle-aged European adults. CONCLUSIONS: Adiponectin levels below the indicated cut-offs may predict a potential risk for the development of IR.
No takes yet. Share an insight, caveat, or question.
Horáková et al. (2018) conducted an observational in Insulin resistance and Type 2 Diabetes Mellitus (n=569). Total and high-molecular-weight adiponectin levels was evaluated on Development of insulin resistance (OR 0.598, 95% CI 0.483-0.723). Increased levels of total adiponectin and its high-molecular-weight form are protective against insulin resistance.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: